BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ikeda M, Wakabayashi Y, Okamoto K, Yanagimoto S, Okugawa S, Moriya K. Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study. AIDS Res Ther 2021;18:30. [PMID: 34044856 DOI: 10.1186/s12981-021-00354-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 White CJ, Gausepohl AM, Seneviratne HK, Bumpus NN, Williams DW. Antiretroviral Therapy Does Not Restore Brain Lipids During SIV Infection: Regional Analysis of Metabolic Homeostasis and Depletion.. [DOI: 10.1101/2022.09.26.508302] [Reference Citation Analysis]
2 Zhang Y, Li Z, Luo Q, Xu W, Wang L, Zhu S, Peng L, Xie C. Changes in blood lipids in patients with chronic hepatitis B after 48 weeks of tenofovir alafenamide treatment: A prospective real-world clinical study. Antiviral Therapy 2022;27:135965352210823. [DOI: 10.1177/13596535221082399] [Reference Citation Analysis]
3 Wood BR, Huhn GD. Excess Weight Gain With Integrase Inhibitors and Tenofovir Alafenamide: What Is the Mechanism and Does It Matter? Open Forum Infect Dis 2021;8:ofab542. [PMID: 34877366 DOI: 10.1093/ofid/ofab542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]